Sunday 24th January 2010
| Immunogenetics of infections | |
| P.Y. Bochud |
| Using TLR4 Polymorphisms to study human migration | |
| M. Netea |
| One world, one health. Healthy animals=Healthy people | |
| W. Winding |
| Influenza pandemic and other threats | |
| K. Rooney |
Monday 25th January 2010
| Community-Acquired Resistant Bacteria: Consequences and Solutions | |
| H. Goossens |
| ESBL and antibiotic resistance | |
| T.R. Walsh |
| Immunotherapy in sepsis | |
| T. Calandra |
| New Challenges in the Diagnosis, Management and Prevention of Central Venous Catheter-Related Infections | |
| A.F. Widmer |
| Neglected Tropical Diseases | |
| F. Rio |
| Multiple Drug Resistant Tuberculosis | |
| F.G.J. Cobelens |
| Global change and vector-borne diseases | |
| J. Cox. |
| Cholera | |
| H.P. Endtz |
Tuesday 26th January 2010
| HIV: Current problems and historical perspective | |
| K. Brinkman |
| HIV and hepatitis co-infection: what are the challenges? | |
| J. Rockstroh |
| HIV resistance against NRTI’s, NRRTI’s, protease inhibitors and entry inhibitors | |
| A.M.J. Wensing |
| Cardiovascular risk in HIV: treatment related or disease-related | |
| J. Lundgren |
| FUN-gi: thoughts on yeasts, moulds and medicine | |
| F.C. Odds |
| Candida: prophylaxis and therapy in ICU | |
| T. Calandra |
| Pathogenesis of fungal infections | |
| M. Netea |
| Management of invasive aspergillosis | |
| B.J. Kullberg |
| Why don’t we stop worrying about MRSA in hospitals? No, we should not stop! | |
| S. Harbarth |
| Why don’t we stop worrying about MRSA in hospitals? Yes, we should stop! | |
| S. Lemmen |
Wednesday 27th January 2010
| PK/PD 1 | |
| J.W. Mouton |
| PK/PD 2 | |
| C.G. Giske |
| Current therapy for hepatitis B and C | |
| I.M. Hoepelman |
| Infectious complications of biologicals | |
| A. Verbon |
| Infections of the eye: immunocompetent versus immunocompromised host | |
| A. Rothova |
| Immunosuppression in transplantation and malignancy: new drugs/ bad bugs | |
| H.H. Hirsch |
| Organ transplantation and viral hepatitis | |
| F. Nevens |
| Clinical Uses of CMV Diagnostics and preemptive therapy in transplantation | |
| P. Griffiths |
Thursday 28th January 2010
| Alveolar Echinococcosis | |
| A. Schweiger |
| Hantavirusinfections and haemorrhagic fever with renal syndrome in European countries | |
| P. Heyman |
| Q-fever in the Netherlands | |
| C.E. Delsing |
| Clostridium difficile-associated diarrhea: epidemiology and diagnosis | |
| M.H. Wilcox |
| Clostridium difficile-associated diarrhea: clinical presentation, treatment and prevention | |
| P. Speelman |
| New treatment options for infections caused by Pseudomonas aeruginosa | |
| J. Chastre |
| Invasive streptococcal infections: epidemiology and optimal treatment | |
| A. Norrby |
| Community acquired MRSA: the European epidemiology | |
| H. de Lencastre |
| Community acquired MRSA: pathogenesis | |
| J. Etienne |
| Combination Antibiotic Therapy bacteremic pneumococcal pneumonia - Pro | |
| A. Torres |
| Combination Antibiotic Therapy bacteremic pneumococcal pneumonia - Con | |
| J. Garau |
Friday 29th January 2010
| Infectious diseases in Vietnam | |
| H.F.L. Wertheim |
| Rational use of antimicrobials in patients with severe acute pancreatitis | |
| J.J. DeWaele |
| Procalcitonin guided antibiotic therapy | |
| B. Mueller |
| Antibiotic stewardship in the hospital | |
| I.M. Gould |
| Why we should use EUCAST breakpoints | |
| G. Kahlmeter |